Ironwood Pharmaceuticals (IRWD) Liabilities from Discontinued Operations (2018)

Ironwood Pharmaceuticals has disclosed Liabilities from Discontinued Operations across 1 years of filings, most recently posting $15.7 million for Q4 2018.

• In Q4 2018, Liabilities from Discontinued Operations changed N/A year-over-year to $15.7 million; the TTM figure through Dec 2018 stood at $15.7 million (changed N/A YoY), while the FY2018 annual figure was $15.7 million, changed N/A from the prior year.
• Liabilities from Discontinued Operations came in at $15.7 million for Q4 2018 at Ironwood Pharmaceuticals.
• In the past five years, Liabilities from Discontinued Operations ranged from a high of $15.7 million in Q4 2018 to a low of $15.7 million in Q4 2018.